US CEO, who spends $2 million a year on age reversal, now using teen son as 'blood boy'

California-based entrepreneur Bryan Johnson is a multimillionaire. And when you have that kind of money, there’s almost nothing you cannot have. And the 45-year-old software developer, with all his wealth, has pledged his unwavering dedication to halt his aging process.

He follows a strict routine and spends a staggering $2 million annually on his quest for eternal youth and believes that regular blood transfusions can keep his internal organs functioning youthfully. And now he has enlisted his 17-year-old son, Talmage, as his personal "blood boy" in a controversial practice known as plasma-swapping.

Recently, Johnson, accompanied by his father Richard, aged 70, visited a clinic near Dallas in Texas for a unique tri-generational blood-swapping treatment. Typically, Johnson receives plasma from anonymous donors, carefully selected to ensure they have an ideal body mass index, a healthy lifestyle, and are free of diseases.

However, on this occasion, Talmage provided a litre of his own blood, which was then processed into separate batches of liquid plasma, red and white blood cells, and platelets. After having his own blood drained, Talmage's plasma was fed into Johnson's veins, enhancing the controversial procedure. Johnson’s father Richard goes in last and gets the same procedure.
While the idea of using plasma as an anti-aging technique gained attention when scientists conducted experiments on mice, the human-based data remains limited. When young and old mice were joined together to share a circulatory system, the older rodents exhibited improvements in cognitive function, metabolism, and bone structure, while the younger subjects showed positive effects from frequent blood donation. However, the efficacy of plasma-swapping as a longevity technique for humans remains inconclusive, leading many researchers to view it sceptically.

Charles Brenner, a biochemist at City of Hope National Medical Center in Los Angeles, expressed his reservations about plasma-swapping, stating, "We have not learned enough to suggest this is a viable human treatment for anything. To me, it's gross, evidence-free, and relatively dangerous." The traditional use of blood plasma involves providing it to patients experiencing trauma, burns, shock, severe liver disease, and clotting deficiencies.